Arsenic induced overexpression of inflammatory cytokines based on the human urothelial cell model in vitro and urinary secretion of individuals chronically exposed to arsenic

Chemical Research in Toxicology

Volumn 27, Issue 11, 2014, Pages 1934-1942

  Liu, Shengnan ^a   Sun, Qingshan ^a   Wang, Fei ^a   Zhang, Lin ^a   Song, Yingli ^a   Xi, Shuhua ^a   Sun, Guifan ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ARSENIC; INTERLEUKIN 8; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; POLLUTANT;

ADULT; AGE; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; COMPARATIVE STUDY; CONTROLLED STUDY; EPITHELIUM CELL; FOOD INTAKE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; OCCUPATIONAL EXPOSURE; PROTEIN URINE LEVEL; SEA FOOD; SMOKING; UROTHELIUM; ANALYSIS; BIOSYNTHESIS; CELL LINE; CYTOLOGY; DRUG EFFECTS; ENVIRONMENTAL EXPOSURE; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGY; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLLUTANT; REAL TIME POLYMERASE CHAIN REACTION; STATISTICAL MODEL; TOXICITY; URINE;

ADULT; ARSENIC; CELL LINE; CYTOKINES; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL POLLUTANTS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITHELIAL CELLS; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; UROTHELIUM;

EID: 84910655900     PISSN: 0893228X     EISSN: 15205010     Source Type: Journal    
DOI: 10.1021/tx5002783     Document Type: Article

References (44)

1. Xi, S., Zheng, Q., Zhang, Q., and Sun, G. (2011) Metabolic profile and assessment of occupational arsenic exposure in copper- and steel-smelting workers in China Int. Arch. Occup. Environ. Health 84, 347-353
2. International Agency for Research on Cancer (IARC) (2004) Arsenic in drinking water 84, Evaluation of arcinogenic Risks to Humans, pp 1-477, Lyon.
3. Grivennikov, S. I., Greten, F. R., and Karin, M. (2010) Immunity, inflammation, and cancer Cell 140, 883-899
4. Michaud, D. S. (2007) Chronic inflammation and bladder cancer Urol. Oncol. 25, 260-268
5. Wang, H., Xi, S., Xu, Y., Wang, F., Zheng, Y., Li, B., Li, X., Zheng, Q., and Sun, G. (2013) Sodium Arsenite Induces Cyclooxygenase-2 Expression in Human Uroepithelial Cells through MAPK Pathway Activation and Reactive Oxygen Species Induction Toxicol. In Vitro 27, 1043-1048
6. Komhoff, M., Guan, Y., Shappell, H. W., Davis, L., Jack, G., Shyr, Y., Koch, M. O., Shappell, S. B., and Breyer, M. D. (2000) Enhanced expression of cyclooxygenase-2 in high grade human transitional cell bladder carcinomas Am. J. Pathol. 157, 29-35
7. Do, T., Gambelunghe, A., Ahsan, H., Graziano, J., Perrin, M., Slavkovich, V., Parvez, F., Milton, A. H., and BrandtRauf, P. (2001) Urinary transforming growth factor-alpha in individuals exposed to arsenic in drinking water in Bangladesh Biomarkers 6, 127-132
8. Valenzuela, O. L., Germolec, D. R., Borja-Aburto, V. H., Contreras-Ruiz, J., García-Vargas, G. G., and Del Razo, L. M. (2007) Chronic arsenic exposure increases TGFalpha concentration in bladder urothelial cells of Mexican populations environmentally exposed to inorganic arsenic Toxicol. Appl. Pharmacol. 222, 264-270
9. Hsu, K. H., Brandt-Rauf, P., Lin, T. M., Chiou, H. Y., Tseng, C. H., Chen, C. J., and Luo, J. C. (2006) Plasma-transforming growth factor-alpha expression in residents of an arseniasis area in Taiwan Biomarkers 11, 538-546
10. Germolec, D. R., Yoshida, T., Gaido, K., Wilmer, J. L., Simeonova, P. P., Kayama, F., Burleson, F., Dong, W., Lange, R. W., and Luster, M. I. (1996) Arsenic induces overexpression of growth factors in human keratinocytes Toxicol. Appl. Pharmacol. 141, 308-318
11. Yeh, Y. C., Tsai, J. F., Chuang, L. Y., Yeh, H. W., Tsai, J. H., Florine, D. L., and Tarn, J. P. (1987) Elevation of transformationing growth factor alpha and its relationship to the epidermal growth factor and alpha-fetoprotein levels in patients with hepatocellular carcinoma Cancer Res. 47, 896-901
12. Narayan, S., Thangasamy, T., and Balusu, R. (2005) Transforming growth factor-beta receptor signaling in cancer Front. Biosci. 10, 1135-1145
13. Morrison, C. D., Parvani, J. G., and Schiemann, W. P. (2013) The relevance of the TGF-β Paradox to EMT-MET programs Cancer Lett. 341, 30-40
14. Shaker, O., Hammam, O., Wishahi, M., and Roshdi, M. (2013) TGF-B1 pathway as biological marker of bladder carcinoma schistosomal and non-schistosomal Urol. Oncol. 31, 372-378
15. McClain, C. J., Song, Z., Barve, S. S., Hill, D. B., and Deaciuc, I. (2004) Recent advances in alcoholic liver disease. IV. Dysregulated cytokine metabolism in alcoholic liver disease Am. J. Physiol. Gastrointest. Liver Physiol. 287, G497-G502
16. Schadendorf, D., M?ller, A., Algermissen, B., Worm, M., Sticherling, M., and Czarnetzki, B. M. (1993) IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor J. Immunol. 151, 2667-2675
17. Das, S., Santra, A., Lahiri, S., and Guha Mazumder, D. N. (2005) Implications of oxidative stress and hepatic cytokine (TNF-alpha and IL-6) response in the pathogenesis of hepatic collagenesis in chronic arsenic toxicity Toxicol. Appl. Pharmacol. 204, 18-26
18. Escudero-Lourdes, C., Wu, T., Camarillo, J. M., and Gandolfi, A. J. (2012) Interleukin-8 (IL-8) overproduction and autocrine cellactivation are key factors in monomethylarsonous acid [MMA(III)]-induced malignant transformation of urothelial cells Toxicol. Appl. Pharmacol. 258, 10-18
19. Xu, Y., Zhao, Y., Xu, W., Luo, F., Wang, B., Li, Y., Pang, Y., and Liu, Q. (2013) Involvement of HIF-2α-mediated inflammation in arsenite-induced transformation of human bronchial epithelial cells Toxicol. Appl. Pharmacol. 272, 542-550
20. Calatayud, M., Gimeno-Alcañiz, J. V., Vélez, D., and Devesa, V. (2014) Trivalent arsenic species induce changes in expression and levels of proinflammatory cytokines in intestinal epithelial cells Toxicol. Lett. 224, 40-46
21. Escudero-Lourdes, C., Medeiros, M. K., Cardenas-Gonzalez, M. C., Wnek, S. M., and Gandolfi, J. A. (2010) Low level exposure to monomethyl arsonous acid-induced the over-production of inflammation-related cytokines and the activation of cell signals associated with tumor progression in a urothelial cell model Toxicol. Appl. Pharmacol. 244, 162-173
22. Liu, S., Wang, F., Yan, L., Zhang, L., Song, Y., Xi, S., Jia, J., and Sun, G. (2013) Oxidative stress and MAPK involved into ATF2 expression in immortalized human urothelial cells treated by arsenic Arch. Toxicol. 87, 981-989
23. Xu, Y., Wang, Y., Li, X., He, M., Xue, P., Fu, J., Wang, H., and Sun, G. (2009) Variations in arsenic methylation capacity and oxidative DNA lesions over a 2-year period in a high arsenic-exposed population Int. Arch. Occup. Environ. Health 82, 251-258
24. Sun, G., Xu, Y., Li, X., Jin, Y., Li, B., and Sun, X. (2007) Urinary arsenic metabolites in children and adults exposed to arsenic in drinking water in Inner Mongolia, China Environ. Health Perspect. 115, 648-652
25. Dranoff, G. (2004) Cytokines in cancer pathogenesis and cancer therapy Nat. Rev. Cancer 4, 11-22
26. Chikazawa, M., Inoue, K., Fukata, S., Karashima, T., and Shuin, T. (2008) Expression of angiogenesis-related genes regulates different steps in the process of tumor growth and metastasis in human urothelial cell carcinoma of the urinary bladder Pathobiology 75, 335-345
27. Feng, C. C., Wang, P. H., Ding, Q., Guan, M., Zhang, Y. F., Jiang, H. W., Wen, H., and Wu, Z. (2013) Expression of pigment epithelium-derived factor and tumor necrosis factor-α is correlated in bladder tumor and is related to tumor angiogenesis Urol. Oncol. 31, 241-246
28. Germolec, D. R., Spalding, J., Yu, H. S., Chen, G. S., Simeonova, P. P., Humble, M. C., Bruccoleri, A., Boorman, G. A., Foley, J. F., Yoshida, T., and Luster, M. I. (1998) Arsenic enhancement of skin neoplasia by chronic stimulation of growth factors Am. J. Pathol. 153, 1775-1785
29. Waugh, D. J. and Wilson, C. (2008) The interleukin-8 pathway in cancer Clin. Cancer Res. 4, 6735-6741
30. Simeonova, P. P., Hulderman, T., Harki, D., and Luster, M. I. (2003) Arsenic exposure accelerates atherogenesis in apolipoprotein E(-/-) mice Environ. Health Perspect. 111, 1744-1748
31. Srivastava, S., Vladykovskaya, E. N., Haberzettl, P., Sithu, S. D., DSouza, S. E., and States, J. C. (2009) Arsenic exacerbates atherosclerotic lesion formation and inflammation in apoE-/-mice Toxicol. Appl. Pharmacol. 241, 90-100
32. Roger, T., Out, T. A., Mukaida, N., Matsushima, K., Jansen, H. M., and Lutter, R. (1998) Enhanced AP-1 and NF-kappaB activities and stability of interleukin 8 (IL-8) transcripts are implicated in IL-8 mRNA superinduction in lung epithelial H292 cells Biochem. J. 330, 429-435
33. Blackwell, T. S. and Christman, J. W. (1997) The role of nuclear factor-kappa B in cytokine gene regulation Am. J. Respir. Cell Mol. Biol. 17, 3-9
34. Yih, L. H., Peck, K., and Lee, T. C. (2002) Changes in gene expression profiles of human fibroblasts in response to sodium arsenite treatment Carcinogenesis 23, 867-876
35. Banerjee, N., Nandy, S., Kearns, J. K., Bandyopadhyay, A. K., Das, J. K., Majumder, P., Basu, S., Banerjee, S., Sau, T. J., States, J. C., and Giri, A. K. (2011) Polymorphisms in the TNF-a and IL10 gene promoters and risk of arsenic-induced skin lesions and other nondermatological health effects Toxicol. Sci. 121, 132-139
36. Ravery, V., Grignon, D., Angulo, J., Pontes, E., Montie, J., Crissman, J., and Chopin, D. (1997) Evaluation of epidermal growth factor receptor, transforming growth factor alpha, epidermal growth factor and c-erbB2 in the progression of invasive bladder cancer Urol. Res. 25, 9-17
37. Wu, J., Liu, J., Waalkes, M. P., Cheng, M. L., Li, L., Li, C. X., and Yang, Q. (2008) High dietary fat exacerbates arsenic induced liver fibrosis in mice Exp. Biol. Med. (Maywood) 233, 377-384
38. Chen, S., Jim, B., and Ziyadeh, F. N. (2003) Diabetic nephropathy and transforming growth factor-beta: transforming our view of glomerulosclerosis and fibrosis build-up Semin. Nephrol. 23, 532-543
39. Border, W. A. and Noble, N. A. (1998) Evidence that TGF-beta should be a therapeutic target in diabetic nephropathy Kidney Int. 54, 1390-1391
40. Eissa, S., Salem, A. M., Zohny, S. F., and Hegazy, M. G. (2007) The diagnostic efficacy of urinary TGF-β1 and VEGF in bladder cancer: Comparison with voided urine cytology Cancer Biomark. 3, 275-285
41. Hopenhayn-Rich, C., Biggs, M. L., Fuchs, A., Bergoglio, R., Tello, E. E., Nicolli, H., and Smith, A. H. (1996) Bladder cancer mortality associated with arsenic in drinking water in Argentina Epidemiology 7, 117-124
42. Pu, Y. S., Yang, S. M., Huang, Y. K., Chung, C. J., Huang, S. K., Chiu, A. W., Yang, M. H., Chen, C. J., and Hsueh, Y. M. (2007) Urinary arsenic profile affects the risk of urothelial carcinoma even at low arsenic exposure Toxicol. Appl. Pharmacol. 218, 99-106
43. Wu, C. C., Huang, Y. K., Chung, C. J., Huang, C. Y., Pu, Y. S., Shiue, H. S., Lai, L. A., Lin, Y. C., Su, C. T., and Hsueh, Y. M. (2013) Polymorphism of inflammatory genes and arsenic methylation capacity are associated with urothelial carcinoma Toxicol. Appl. Pharmacol. 272, 30-36
44. Tungekar, M. F. and Linehan, J. (1998) Patterns of expressions of transforming growth factor and epidermal growth factor receptor in squamous cell lesions of the urinary bladder J. Clin. Pathol. 51, 583-587